Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Godfrey (Luxemburg, Luxemburg). What regulatory framework is preferable for successful harm reduction?. Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies

Member's Comments

No comment yet.

Related content which might interest you: A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction Source: Eur Respir J, 55 (5) 2000166; 10.1183/13993003.00166-2020 Year: 2020 A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction Source: Eur Respir J, 55 (5) 2000355; 10.1183/13993003.00355-2020 Year: 2020 What makes a situation challenging? How to implement a communication approach Source: Virtual Congress 2020 – How to deal with difficult people Year: 2020 Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Do we need a gender-specific approach for health interventions? Source: Virtual Congress 2021 – Highlights on gender and respiratory health Year: 2021 What makes a team effective? Source: Virtual Congress 2020 – Teamability: becoming an effective team leader and member Year: 2020 Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 Was the implementation strategy of the ProACT trial adequately proactive? Source: Breathe, 15 (1) 77; 10.1183/20734735.0338-2018 Year: 2019 Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Rethinking the way we are treating established airway disease: current guidelines need to change  Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma Year: 2016 Aiming for total control in asthma: an ineffective use of resources? Source: Eur Respir J 2005; 26: Suppl. 49, 429s Year: 2005 The need and potential of patient-specific modelling Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop Year: 2012 Scaling-up global implementation of LTBI management: a paradigm shift needed Source: International Congress 2016 – ERS and tuberculosis Year: 2016